Medlab Clinical Ltd
ASX:MDC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Micro Systemation AB (publ)
STO:MSAB B
|
SE |
Medlab Clinical Ltd
Interest Expense
Medlab Clinical Ltd
Interest Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medlab Clinical Ltd
ASX:MDC
|
Interest Expense
AU$500
|
CAGR 3-Years
-85%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mesoblast Ltd
ASX:MSB
|
Interest Expense
$22.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Interest Expense
$421m
|
CAGR 3-Years
12%
|
CAGR 5-Years
24%
|
CAGR 10-Years
21%
|
|
|
Race Oncology Ltd
ASX:RAC
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Interest Expense
AU$13.8m
|
CAGR 3-Years
295%
|
CAGR 5-Years
154%
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Interest Expense
AU$57.6k
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Medlab Clinical Ltd
Glance View
Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. The company is headquartered in Alexandria, New South Wales. The company went IPO on 2015-07-14. Medlab’s pipeline comprises a number of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The firm's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use. The firm also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory. NanoCelle is designed to address known medication problems, addressing global unmet medical needs. Medlab operates in Australia, United States, and the United Kingdom.
See Also
What is Medlab Clinical Ltd's Interest Expense?
Interest Expense
500
AUD
Based on the financial report for Jun 30, 2024, Medlab Clinical Ltd's Interest Expense amounts to 500 AUD.
What is Medlab Clinical Ltd's Interest Expense growth rate?
Interest Expense CAGR 3Y
-85%
Over the last year, the Interest Expense growth was -98%. The average annual Interest Expense growth rates for Medlab Clinical Ltd have been -85% over the past three years .
